Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-19

Clinical Trial Update: R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing R-ABVD to ABVD-RT in early-stage Hodgkin lymphoma; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABVD-RT
  • R-ABVD

Snippet

Sponsor: Fondazione Michelangelo | Conditions: Hodgkin Lymphoma | Phase 3 | Status: TERMINATED